Xiaoyan Ding Selected Research

Familial Exudative Vitreoretinopathies

1/2023	ULTRA-WIDEFIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN MILD FAMILIAL EXUDATIVE VITREORETINOPATHY.
1/2023	Five novel dysfunctional variants in the TSPAN12 gene in familial exudative vitreoretinopathy.
1/2023	Pattern of choroidal thickness in early-onset high myopia.
1/2023	NDP-related retinopathies: clinical phenotype of female carriers.
1/2022	CTNND1 variants cause familial exudative vitreoretinopathy through the Wnt/cadherin axis.
1/2021	Ultra-wide-field scanning laser ophthalmoscopy and optical coherence tomography in FEVR: findings and its diagnostic ability.
1/2020	The spectrum of genetic mutations in patients with asymptomatic mild familial exudative vitreoretinopathy.
1/2019	Symmetry of folds in FEVR: A genotype-phenotype correlation study.
1/2019	Novel ocular findings in oculodentodigital dysplasia (ODDD): a case report and literature review.
12/2014	Posterior pole retinal abnormalities in mild asymptomatic FEVR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaoyan Ding Research Topics

Disease

22	Neoplasms (Cancer) 04/2024 - 09/2003
13	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 01/2018
10	Familial Exudative Vitreoretinopathies 01/2023 - 12/2014
8	Infections 06/2023 - 09/2010
8	Choroidal Neovascularization 01/2021 - 01/2008
7	Retinal Detachment (Retinal Detachments) 01/2022 - 03/2003
6	Macular Degeneration (Age-Related Maculopathy) 01/2024 - 04/2008
6	Neoplasm Metastasis (Metastasis) 12/2023 - 08/2012
6	Pre-Eclampsia (Preeclampsia) 12/2015 - 01/2014
5	Atrophy 01/2024 - 01/2008
5	Carcinogenesis 10/2023 - 12/2010
5	Inflammation (Inflammations) 05/2023 - 01/2009
4	Tuberculosis (Tuberculoses) 12/2024 - 01/2018
4	Mitochondrial Diseases (Mitochondrial Disease) 12/2023 - 10/2015
4	Toxocariasis 01/2023 - 01/2021
4	Cataract (Cataracts) 01/2023 - 09/2009
4	Disease Progression 01/2022 - 08/2009
4	Breast Neoplasms (Breast Cancer) 11/2015 - 09/2003
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 01/2019
3	Fibrosis (Cirrhosis) 05/2023 - 11/2018
3	Uveitis 01/2023 - 04/2008
3	Body Weight (Weight, Body) 05/2022 - 01/2015
3	Hypoxia (Hypoxemia) 01/2022 - 12/2008
3	Liver Neoplasms (Liver Cancer) 01/2022 - 01/2018
3	Retinoschisis (Retinoschisis, Juvenile) 11/2021 - 08/2012
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2018 - 01/2012
3	Triple Negative Breast Neoplasms 04/2017 - 11/2015
3	Neovascular Glaucoma 01/2016 - 06/2013
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 12/2015 - 01/2014
2	Metabolic Diseases (Metabolic Disease) 04/2024 - 01/2021
2	Pathologic Neovascularization 03/2024 - 07/2023
2	Myopia 01/2024 - 01/2023
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2024 - 02/2023
2	Cholangiocarcinoma 12/2023 - 01/2022
2	Ovarian Neoplasms (Ovarian Cancer) 10/2023 - 06/2012
2	Retinal Neovascularization 07/2023 - 01/2023
2	Thrombosis (Thrombus) 01/2023 - 10/2021
2	Blindness (Hysterical Blindness) 01/2023 - 08/2009
2	COVID-19 02/2022 - 06/2020
2	Adenocarcinoma of Lung 02/2022 - 01/2022
2	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2021
2	Granuloma 01/2022 - 10/2021
2	Ischemia 01/2022 - 12/2008
2	Hypertension (High Blood Pressure) 01/2022 - 05/2015
2	Refractive Errors (Refractive Error) 01/2021 - 06/2013
2	Glaucoma 01/2019 - 09/2009
2	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 10/2016 - 10/2016
2	Pathologic Processes 10/2016 - 03/2013
2	Endometriosis 12/2010 - 10/2010
2	Adenomyosis 12/2010 - 10/2010
1	Rare Diseases (Rare Disease) 04/2024
1	Liver Diseases (Liver Disease) 04/2024

Drug/Important Bio-Agent (IBA)

24	Retinaldehyde (Retinal)IBA 03/2024 - 01/2008
11	Proteins (Proteins, Gene)FDA Link 05/2022 - 09/2003
9	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 05/2011
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2010
8	lenvatinibIBA 01/2024 - 10/2021
6	Messenger RNA (mRNA)IBA 01/2022 - 09/2003
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2009
6	Fatty Acids (Saturated Fatty Acids)IBA 12/2015 - 08/2009
5	CytokinesIBA 02/2022 - 10/2016
4	Ranibizumab (Lucentis)FDA Link 01/2021 - 01/2016
4	arginine methyl esterIBA 12/2015 - 01/2014
3	Rifampin (Rifampicin)FDA LinkGeneric 12/2024 - 01/2012
3	Nucleic AcidsIBA 04/2024 - 07/2023
3	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2022
3	alpha-Fetoproteins (alpha-Fetoprotein)IBA 10/2023 - 01/2022
3	Fluorescein (Funduscein)FDA LinkGeneric 01/2023 - 12/2017
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 01/2016
3	LipopolysaccharidesIBA 12/2015 - 01/2014
3	3-Hydroxyacyl-CoA DehydrogenaseIBA 10/2015 - 01/2014
3	VaccinesIBA 01/2013 - 09/2010
2	CateninsIBA 12/2023 - 01/2022
2	bufalinIBA 12/2023 - 10/2023
2	Amyloid (Amyloid Fibrils)IBA 10/2023 - 12/2019
2	Transcription Factors (Transcription Factor)IBA 05/2023 - 10/2022
2	Angiotensin-Converting Enzyme 2IBA 01/2023 - 02/2022
2	Cysteine (L-Cysteine)FDA Link 01/2023 - 01/2019
2	camrelizumabIBA 01/2023 - 01/2022
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	sintilimabIBA 01/2022 - 01/2022
2	thiamine triphosphorate (TTP)IBA 01/2022 - 10/2021
2	Circular RNAIBA 01/2022 - 01/2020
2	Tuberculin (PPD)IBA 12/2021 - 01/2018
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2013
2	Interleukin-2 (IL2)IBA 01/2020 - 01/2018
2	ClaudinsIBA 01/2019 - 01/2014
2	Indicators and Reagents (Reagents)IBA 04/2017 - 11/2016
2	ChemokinesIBA 01/2016 - 12/2008
2	Bevacizumab (Avastin)FDA Link 06/2013 - 05/2011
2	AntibodiesIBA 01/2013 - 09/2010
2	fludarabineIBA 09/2010 - 02/2008

Therapy/Procedure

13	Therapeutics 04/2024 - 08/2009
8	Lasers (Laser) 01/2023 - 12/2010
6	Aftercare (After-Treatment) 01/2024 - 02/2009
3	Drug Therapy (Chemotherapy) 02/2022 - 02/2008
3	Vitrectomy 01/2020 - 03/2003
2	Immunotherapy 10/2023 - 01/2018
2	Intraperitoneal Injections 11/2018 - 10/2015
2	Intravitreal Injections 01/2016 - 06/2013